Yiqiu Yao
Overview
Explore the profile of Yiqiu Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahl R, Poggi A, Nielsen V, Yao Y, Patsi I, Poulsen S, et al.
Endocrinol Diabetes Metab
. 2024 Oct;
7(6):e70002.
PMID: 39358901
Objective: Tumour necrosis factor (TNF)-α is a proinflammatory marker and has been shown to affect mitochondrial function in different tissues. We investigated the effect on adipose tissue (AT) inflammation and...
2.
Gyldenlove M, Meteran H, Sorensen J, Fage S, Yao Y, Lindhardsen J, et al.
Lancet Reg Health Eur
. 2023 Jul;
30:100639.
PMID: 37465323
Background: Roflumilast is a targeted inhibitor of phosphodiesterase (PDE)-4 and has been approved for treatment of severe chronic obstructive pulmonary disease for more than a decade. Generic versions are available...
3.
Characteristics of patients with hidradenitis suppurativa and concomitant inflammatory bowel disease
Nielsen V, Jorgensen A, Yao Y, Ring H, Attauabi M, Madsen G, et al.
Int J Dermatol
. 2023 Feb;
62(6):e321-e323.
PMID: 36841891
No abstract available.
4.
Yao Y, Ghazanfar M, Jorgensen A, Ring H, Thomsen S
Case Rep Dermatol
. 2023 Jan;
15(1):5-9.
PMID: 36619701
Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was...
5.
Holm Nielsen S, Groen S, Yao Y, Jorgensen A, Nielsen V, Karsdal M, et al.
J Invest Dermatol
. 2022 Sep;
143(2):328-331.e3.
PMID: 36108804
No abstract available.
6.
Attauabi M, Madsen G, Bendtsen F, Wewer A, Wilkens R, Ilvemark J, et al.
BMJ Open
. 2022 Jun;
12(6):e055779.
PMID: 35760545
Introduction: Inflammatory bowel diseases (IBD), encompassing Crohn's disease and ulcerative colitis, are chronic, inflammatory diseases of the gastrointestinal tract. We have initiated a Danish population-based inception cohort study aiming to...
7.
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
Ring H, Yao Y, Maul J, Ingram J, Frew J, Thorsen J, et al.
Br J Dermatol
. 2022 May;
187(4):523-530.
PMID: 35603888
Background: Prolonged systemic antibiotic treatment is often a part of management of hidradenitis suppurativa (HS). Although biologic therapies are now available, the patient's treatment journey leading to biologic therapy is...
8.
Nielsen V, Yao Y, Holm J, Jorgensen A, Ring H, Hornum M, et al.
Health Sci Rep
. 2022 Mar;
5(2):e535.
PMID: 35284649
No abstract available.
9.
Jorgensen A, Nielsen V, Yao Y, Ring H, Thomsen S
Skinmed
. 2022 Jan;
19(6):432-437.
PMID: 35022114
We examined the prevalence and risk factors of anemia in patients with hidradenitis suppurativa (HS). The presence of anemia and information on risk factors was obtained through interview, clinical examination,...
10.
Ring H, Maul J, Yao Y, Wu J, Thyssen J, Thomsen S, et al.
JAMA Dermatol
. 2021 Dec;
158(2):184-188.
PMID: 34851360
Importance: Biologics are important in treating patients with hidradenitis suppurativa (HS). However, to our knowledge, data on their real-life performance and treatment patterns in HS are limited. Objective: To examine...